Navigation Links
Raptor Pharmaceuticals Provides Update of Product Programs
Date:9/13/2007

Poster at Upcoming International Liver Cancer Conference

Status of Ongoing Programs

Regulatory Consulting Firm Retained

NOVATO, Calif., Sept. 13 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP.OB) announced today that Dr. Todd Zankel, the Company's Chief Scientific Officer, will present a poster detailing promising preclinical results from two preclinical studies of its HepTide(TM) liver targeting program at the International Liver Cancer ("ILCA") Conference, to be held October 5-7, 2007 in Barcelona, Spain.

Dr. Zankel's presentation will include an update on Raptor's liver targeting platform based on human receptor-associated protein ("RAP"). For more information on ILCA and the 2007 ILCA Conference, please visit http://www.ilca-online.org. A synopsis of the poster will be available in the investor relations section of Raptor's website at http://www.raptorpharma.com shortly after Dr. Zankel presents at the conference.

Current Program Updates:

Investigational New Drug Application ("IND")-Enabling Studies Initiated for HepTide(TM)

Based on promising results from ongoing preclinical studies of its RAP liver targeting program, Raptor has initiated a pre-IND program for HepTide(TM) (its liver targeting therapeutic conjugate using the RAP targeting platform). The Company's goal is to file an IND for this therapeutic conjugate with the Food and Drug Administration (the "FDA") by the end of the second calendar quarter of 2008. To help execute this plan the Company has retained Regulatory Professionals, Inc., a regulatory consulting firm experienced in working with the FDA in all aspects of regulatory affairs including preclinical and clinical support for pre- and post-approval products, and preparation and submis
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 This study provides an analysis ... solutions including nuclear imaging informatics, PET imaging informatics, ... assesses the size of the market based on ... projects future growth based on the current drivers ... place in the broader markets for imaging equipment, ...
(Date:9/30/2014)... 2014  Decision Resources Group finds that the Asia ... China , India , ... rate through 2023. Dental implant procedure volumes will grow as physicians ... Other key findings from Decision Resources Group,s coverage of ... , Dental implant penetration: Penetration of dental implants among ...
(Date:9/30/2014)... -- A study using a relatively new imaging tool, ... the composition of carotid artery disease and has the ... disease, a leading cause of stroke. ... 2010 and May 2012, was featured in the June ... College of Cardiology (JACC) Cardiovascular Interventions. Interventional cardiologist ...
Breaking Medicine Technology:Analysis of the US Molecular Imaging Informatics Market 2Analysis of the US Molecular Imaging Informatics Market 3Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2
(Date:10/1/2014)... (PRWEB) October 01, 2014 Join the more ... Eating Disorder Treatment Center’s first ever charity golf tournament to ... people with eating disorders who cannot afford treatment. The tournament ... Club in Eureka, Mo. , The day-long event starts ... A reception and award dinner will begin at 5 p.m. ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Beverly Hills ... Kathleen Mojas is celebrating 20 years of private practice ... hundreds of people to achieve greater joy and fulfillment ... list of warning signs and suggestions for anyone who ... Mojas explains: “Believe it or not, it’s not ...
(Date:10/1/2014)... Jupiter, FL (PRWEB) October 01, 2014 ... Begley, Jr., scheduled to broadcast on Monday, October 20, ... In this episode, Innovations will go behind the scenes ... prevention programs. This segment will explore the practical help ... young adults, which teaches the warning signs of abuse, ...
(Date:10/1/2014)... 01, 2014 NoteSwift Inc., announced today ... 10.0, 12.1 and 13.0. NoteSwift is the bridge between ... to navigate and document clinical information at the point ... creating a patient note by more than half – ... major pain points providers state impedes EHR use according ...
(Date:10/1/2014)... Scientists at the University of Western ... immune system proteins has the power to knock out ... of the new study on their website. Click ... in the UWA School of Pathology and Laboratory Medicine ... with mesothelioma with promising results. , “A timed ...
Breaking Medicine News(10 mins):Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 3Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2Health News:NoteSwift Joins Allscripts Developer Program 2Health News:NoteSwift Joins Allscripts Developer Program 3Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2
... nitrogen-containing bisphosphonate (N-BP) cancer drugs, used to relieve bone ... has been almost entirely unknown. Researchers writing in BioMed ... used ,barcoded, yeast mutants to identify new biological processes ... opportunities for the development of new anticancer drugs. ...
... LOS ANGELES, Sept. 9 In commemoration of the first ... Red Cross of Greater Los Angeles will host three 2-hour volunteer orientations ... volunteers will receive a tour of the chapter,s new state of the ... Cross, response to the recent California wildfires. , , ...
... WASHINGTON, Sept. 9 Congressman Chaka Fattah (D-PA), a strong ... conclusion of President Obama,s address tonight to Congress and the nation: ... The time to act is now. We have been talking and ... of this 111th Congress. The American people have already voted: In ...
... , INDIANAPOLIS, Sept. 9 WellPoint, Inc. (NYSE: ... Medicare Advantage and 2010 Medicare Part D health benefit plans effective Oct. ... Medicare Part D health benefit plans on Nov. 15, 2009 for the ... Medicare and Medicaid Services (CMS) has determined that WellPoint has corrected deficiencies ...
... , DENVER, Sept. 9 DaVita Inc. (NYSE: ... for those diagnosed with chronic kidney disease (CKD), supports dialysis patients, ... standards and social circumstances. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO ... your everyday student at Hollywood High School in Los Angeles, CA ...
... infection known as Trichomonas vaginalis is associated ... study published online September 9 in the Journal ... Stark, ScD, of the department of epidemiology at the ... conducted a case-control study nested within the Physicians, Health ...
Cached Medicine News:Health News:Red Cross Participates in September 11th National Day of Service and Remembrance 2Health News:Statement on WellPoint's Re-Entry into Medicare Market 2Health News:DaVita's Patient-Centric Modalities Offer Students with Kidney Disease More Choices 2Health News:JNCI news brief: STD confirmed to be associated with increased risk of prostate cancer 2
... an interventional guidance device that uses ... the accuracy of computed tomography (CT)-guided ... accuracy, SimpliCT® also has the potential ... puncture procedures including biopsies and fluid ...
ELVeS™ (Endo Laser Vein System) from biolitec is a versatile, easy to use & complete system that allows you to treat all conditions resulting from venous incompetence. (ELVeS has FDA clearance ...
... QuadraLase™ is a unique ... cap that may be rotated ... positions: like having four fibers ... be used for vaporization and ...
... the first truly lateral, all quartz fiber. ... (NA) compression technology for Total Internal Reflection ... The resulting output is virtually indistinguishable from ... transmission efficiency in a round spot of ...
Medicine Products: